Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $238.21 Analyst target: $248.90 Upside: 4.49%
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.
See the full interactive analysis & chart →Informational only — not investment advice.